Medicare Enrolled
Dr. Robert Igwe, M.D.
Endocrinology · Berkley, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Igwe from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Igwe?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Igwe
Dr. Robert Igwe is an endocrinology specialist in Berkley, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Igwe performed 2,278 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Igwe received a total of $164,786 from 64 pharmaceutical and/or device companies across 981 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Igwe is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 14% volume in MI
$164,786 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,278
Medicare services
Top 14% in MI for endocrinology
Not available
Unique patients (not deduplicated)
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
657 | $90 | $140 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
447 | $40 | $70 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
283 | $63 | $115 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
269 | $129 | $205 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
232 | $26 | $75 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
101 | $136 | $280 |
| New patient office visit, complex (60-74 min) | 72 | $158 | $295 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
63 | $3 | $37 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
35 | $10 | $150 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
28 | $16 | $50 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
28 | $115 | $225 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
27 | $9 | $50 |
| Hemoglobin analysis by chromatography A laboratory test that uses chromatography to separate and measure different types of hemoglobin in the blood. |
21 | $18 | $35 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
15 | $13 | $70 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$164,786
Total received (2018-2024)
Avg $23,541/year across 7 years
Top 7% in MI for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
64
Companies
981
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,748
2023
$2,846
2022
$15,529
2021
$20,650
2020
$19,470
2019
$35,280
2018
$66,263
Payments by company (2024)
Abbott Laboratories
$1,881
Lilly USA, LLC
$445
Amgen Inc.
$423
Dexcom, Inc.
$284
Novo Nordisk Inc
$252
Xeris Pharmaceuticals, Inc.
$185
Boehringer Ingelheim Pharmaceuticals, Inc.
$184
GENZYME CORPORATION
$158
Bayer Healthcare Pharmaceuticals Inc.
$97
Radius Health, Inc.
$86
Insulet Corporation
$79
Corcept Therapeutics
$69
SANOFI-AVENTIS U.S. LLC
$62
Tolmar, Inc.
$59
Neurocrine Biosciences, Inc.
$54
Medtronic, Inc.
$51
Esperion Therapeutics, Inc.
$47
Tandem Diabetes Care, Inc.
$45
Astellas Pharma US Inc
$45
Mannkind Corporation
$34
Amneal Pharmaceuticals LLC
$22
Alvogen Inc
$21
RECORDATI_RARE_DISEASES_INC.
$20
Amphastar Pharmaceuticals, Inc.
$20
Alexion Pharmaceuticals, Inc.
$19
PFIZER INC.
$19
IBSA Pharma Inc.
$18
Ascensia Diabetes Care Us Inc.
$17
CeQur Corporation
$16
TheracosBio, LLC
$15
Acella Pharmaceuticals, LLC
$14
BETA BIONICS, INC.
$9
Top 3 companies account for 57.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$51,446
Novo Nordisk Inc
$30,504
Lilly USA, LLC
$27,739
Janssen Pharmaceuticals, Inc
$25,362
SANOFI-AVENTIS U.S. LLC
$19,396
Abbott Laboratories
$2,339
Dexcom, Inc.
$937
Amgen Inc.
$800
Boehringer Ingelheim Pharmaceuticals, Inc.
$579
Xeris Pharmaceuticals, Inc.
$447
Becton, Dickinson and Company
$382
Mannkind Corporation
$373
Corcept Therapeutics
$324
Radius Health, Inc.
$301
Insulet Corporation
$276
Horizon Therapeutics plc
$223
Tandem Diabetes Care, Inc.
$202
DEXCOM, INC.
$182
Ascendis Pharma Inc
$161
GENZYME CORPORATION
$158
Amneal Pharmaceuticals LLC
$157
Alvogen Inc
$146
MannKind Corporation
$129
Medtronic, Inc.
$125
IBSA Pharma Inc.
$122
Bayer Healthcare Pharmaceuticals Inc.
$115
Merck Sharp & Dohme Corporation
$101
Alexion Pharmaceuticals, Inc.
$101
ABBVIE INC.
$98
Medtronic MiniMed, Inc.
$93
RECORDATI_RARE_DISEASES_INC.
$89
Bayer HealthCare Pharmaceuticals Inc.
$87
LifeScan, Inc.
$85
Ipsen Biopharmaceuticals, Inc
$81
Astellas Pharma US Inc
$71
Ultragenyx Pharmaceutical Inc.
$71
Esperion Therapeutics, Inc.
$66
Amarin Pharma Inc.
$66
LIFESCAN, INC.
$65
Tolmar, Inc.
$59
Antares Pharma, Inc.
$56
Clarus Therapeutics Inc.
$56
Embecta Corp.
$55
Neurocrine Biosciences, Inc.
$54
AbbVie Inc.
$53
Amryt Pharma Holdings Ltd
$47
Supernus Pharmaceuticals, Inc.
$46
PFIZER INC.
$46
CeQur Corporation
$45
AbbVie, Inc.
$31
EUSA Pharma (US) LLC
$30
Ascensia Diabetes Care US Inc.
$22
Averitas Pharma Inc.
$22
Amphastar Pharmaceuticals, Inc.
$20
Zealand Pharma US, Inc.
$18
Ascensia Diabetes Care Us Inc.
$17
Acerus Pharmaceuticals Corporation
$16
Shire North American Group Inc
$16
Aytu BioScience, Inc
$15
TheracosBio, LLC
$15
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$14
Acella Pharmaceuticals, LLC
$14
GRT US Holding, Inc.
$12
BETA BIONICS, INC.
$9
Top 3 companies account for 66.6% of all-time payments
Associated products mentioned in payments ›
AFREZZA · ASCENDA · BAQSIMI · BD Nano · BD Nano 2nd Gen Pen Needle · BELSOMRA · BYDUREON · Brenzavvy · CYCLOSET · CeQur Simplicity · Corlanor · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · DIABETES - DISEASE · Dexcom CGM · Dexcom G6 Transmitter · ELIGARD · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FREESTYLE LIBRE PRO · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN R 500 · HUMULIN U · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · ISTURISA · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LICART · LYUMJEV · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · Minimed 770G System · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · NP Thyroid 60 · Natesto · ONETOUCH VERIO FLEX · ONETOUCH VERIO REFLECT · OT Verio Flex Starter Kit · OT Verio Reflect "One Touch Meter and Strips" · OTREXUP · Omnipod · OneTouch · OneTouch Verio Reflect · Ozempic · Prolia · QUTENZA · Qutenza · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLUJAN · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Strensiq · Sylvant · Synthroid · TEPEZZA · TERIPARATIDE · TLANDO · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UBRELVY · UNITHROID · Vascepa · Veozah · Victoza · Wegovy · XARELTO · ZEGALOGUE · ZEPBOUND · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
82
County median income
$95,296
Nearest hospital to ZIP centroid (approximate)
BEAUMONT HOSPITAL ROYAL OAK
1.8 mi
1.8 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Igwe is a clinical cardiology specialist, with above-average Medicare volume (top 14% in MI), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Igwe experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Igwe performed 657 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Igwe receive payments from pharmaceutical companies?
Yes. Dr. Igwe received a total of $164,786 from 64 companies across 981 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Igwe's costs compare to other endocrinologists in Berkley?
Dr. Igwe's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Igwe) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Berkley
Browse endocrinologists in Berkley ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in MI
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in MI
Which MI endocrinologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology